Malignant Lymphoma
📧 Sign up to get email alerts when something new happens for Malignant Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: EchoTip AcuCore Post-Market Clinical Study
Completed post-market clinical study update for the EchoTip AcuCore device, detailing the completion of the post-market evaluation.
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: A Phase I Clinical Study of JS004 in Subjects With Recurrent/Refractory Malignant Lymphoma of China [Phase 1]
Phase I clinical study of JS004 in subjects with recurrent or refractory malignant lymphoma in China has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: A Randomized, Comparative, Double-blind Trial of Pentaisomaltose and Dimethyl Sulphoxide for Cryoprotection of Hematopoietic Stem Cells in Subjects With Multiple Myeloma or Malignant Lymphoma With a Need for Autologous Transplantation [Phase 4]
A Phase 4 randomized, double-blind trial evaluating pentaisomaltose versus dimethyl sulfoxide for cryoprotection of autologous hematopoietic…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis [Phase 3]
Phase 3 clinical trial evaluating a post-transplant immunomodulatory regimen (cyclophosphamide, abatacept, vedolizumab, and a calcineurin in…
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: A Study of KRN125 in Patients With Multiple Myeloma and Malignant Lymphoma [Phase 2]
Phase 2 clinical trial update for KRN125 in patients with multiple myeloma and malignant lymphoma has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-10-23Clinical Trial Update: Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma [Phase 1]
Phase 1 dose-escalation study of ARQ 092 in adults with advanced solid tumors and recurrent malignant lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-02Clinical Trial Update: Healthy Donor Study II - Comparing Plerixafor With G-CSF and Plerixafor [Phase 2]
Phase 2 healthy donor study comparing plerixafor with G-CSF and plerixafor alone for stem cell mobilization; the trial is completed.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies [NA]
Clinical trial update for fludarabine-based conditioning prior to allogeneic transplantation in advanced hematologic malignancies; study com…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma [EARLY_Phase 1]
A completed early-phase 1 safety study evaluating the combination of Velcade (bortezomib) and G-CSF in patients with multiple myeloma or mal…
-
CLINICAL_TRIALS trial_result · 2015-06-25Clinical Trial Update: Stem Cell Factor (SCF) Priming of Haematopoietic Stem Cell Grafts in Malignant Lymphoma [Phase 2]
Phase 2 trial update on stem cell factor (SCF) priming of haematopoietic stem cell grafts in malignant lymphoma, with the study terminated.
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Influence of Ketoconazole on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer [Phase 1]
Phase 1 trial evaluating how ketoconazole affects romidepsin pharmacokinetics in patients with hematologic malignancy and malignant lymphoma…
-
CLINICAL_TRIALS trial_result · 2013-05-13Clinical Trial Update: Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer [Phase 1]
Phase 1 study evaluating how Rifampin affects the pharmacokinetics of romidepsin in patients with advanced cancer, completed with results po…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: p-AKT Expression on Clinical Outcomes in Malignant Lymphoma
This clinical trial update examines the relationship between p-AKT expression and clinical outcomes in malignant lymphoma.